drugset / Trial / NCT03280277
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
Phase 0
Terminated
2 enrolled
OHSU Knight Cancer Institute
Oregon Health and Science University · collabRadiological Society of North America · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This pilot clinical trial studies how well ferumoxytol-enhanced magnetic resonance imaging (MRI) works in imaging lymph nodes in patients with rectal cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Ferumoxytol is a form of very small iron particles that are taken up by cells in normal lymph nodes and may work better in imaging patients with rectal cancer when given with MRI.
Timeline
- Start
- 2018-04-27
- Primary completion
- 2021-08-26
- Completion
- 2021-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxytol | Diagnostic / imaging agent | — | Intravenous |